AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 29634648 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle exercise (≥130 hours/year)
Number of subjects: 116
Study 27109456 — intervention group
Group type: COMPARATOR
Intervention: Plastic stents
Number of subjects: 86
Study 27109456 — intervention group
Group type: EXPERIMENTAL
Intervention: FCSEMSs
Number of subjects: 86
Study 24583059 — intervention group
Group type: EXPERIMENTAL
Intervention: ALV003
Number of subjects: 41
Study 24583059 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 41
Study 23369765 — intervention group
Group type: EXPERIMENTAL
Intervention: Group-based adaptation of the Diabetes Prevention Program lifestyle intervention
Number of subjects: 0
Study 23369765 — intervention group
Group type: EXPERIMENTAL
Intervention: Health care-community partnership
Number of subjects: 0
Study 21457065 — intervention group
Group type: EXPERIMENTAL
Intervention: Pioglitazone + Metformin (PM)
Number of subjects: 288
Study 21457065 — intervention group
Group type: COMPARATOR
Intervention: Metformin + Glimepiride (GM)
Number of subjects: 288
Study 18339222 — intervention group
Group type: EXPERIMENTAL
Intervention: DHA-rich tuna fish oil (6 g fish oil/d, DHA 1.56 g/d, EPA 0.36 g/d)
Number of subjects: 65
Study 18339222 — intervention group
Group type: COMPARATOR
Intervention: Sunflower-seed oil (placebo)
Number of subjects: 65
Study 16545929 — intervention group
Group type: EXPERIMENTAL
Intervention: Magnesium sulfate (MgSO(4)) 250 mg/kg intravenous solution
Number of subjects: 47
Study 16545929 — intervention group
Group type: COMPARATOR
Intervention: Isotonic saline (0.9%)
Number of subjects: 47
Study 12702620 — intervention group
Group type: EXPERIMENTAL
Intervention: Behavioural counselling
Number of subjects: 271
Study 12702620 — intervention group
Group type: COMPARATOR
Intervention: Nutrition education counselling
Number of subjects: 271
Study 11094664 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenoxicam 20 mg intravenously
Number of subjects: 30
Study 11094664 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study 8883683 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling pad applied to the knee postoperatively set at 40 to 50 degrees F
Number of subjects: 0
Study 8883683 — intervention group
Group type: COMPARATOR
Intervention: Cooling pad applied to the knee postoperatively set at 70 to 80 degrees F
Number of subjects: 0
Study 8883683 — intervention group
Group type: EXPERIMENTAL
Intervention: Ice packs
Number of subjects: 0
Study 8883683 — intervention group
Group type: COMPARATOR
Intervention: No cold therapy
Number of subjects: 0
Study 1407495 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed head injury patients with brain lesions
Number of subjects: 0
Study 1407495 — intervention group
Group type: COMPARATOR
Intervention: Patients with posterior cerebral excisions (mainly for tumours)
Number of subjects: 0
Study 1407495 — intervention group
Group type: EXPERIMENTAL
Intervention: CHI patients with non-frontal parenchymal lesions
Number of subjects: 0
Study 3768778 — intervention group
Group type: EXPERIMENTAL
Intervention: Dye cardiac output measurement at rest
Number of subjects: 1022
Study 3768778 — intervention group
Group type: EXPERIMENTAL
Intervention: Fick cardiac output measurement at rest
Number of subjects: 1022
Study 3768778 — intervention group
Group type: EXPERIMENTAL
Intervention: Dye cardiac output measurement during exercise
Number of subjects: 1022
Study 3768778 — intervention group
Group type: EXPERIMENTAL
Intervention: Fick cardiac output measurement during exercise
Number of subjects: 1022
Study 3768778 — intervention group
Group type: COMPARATOR
Intervention: Comparison of Fick and dye methods
Number of subjects: 1022
Study 29564722 — intervention group
Group type: EXPERIMENTAL
Intervention: Pixantrone monotherapy
Number of subjects: 140
Study 26277862 — intervention group
Group type: EXPERIMENTAL
Intervention: PVAI alone (group 1)
Number of subjects: 52
Study 26277862 — intervention group
Group type: EXPERIMENTAL
Intervention: PVAI + LAPW isolation (group 2)
Number of subjects: 52
Study 25231836 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolically healthy patients
Number of subjects: 1002
Study 25231836 — intervention group
Group type: COMPARATOR
Intervention: Metabolically abnormal patients
Number of subjects: 1002
Study 25231836 — intervention group
Group type: EXPERIMENTAL
Intervention: Metabolically abnormal subjects
Number of subjects: 1002
Study 22938914 — intervention group
Group type: EXPERIMENTAL
Intervention: PM (physician management)
Number of subjects: 47
Study 22938914 — intervention group
Group type: COMPARATOR
Intervention: PM+EMM (physician management plus enhanced medical management)
Number of subjects: 47
Study 22938914 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 47
Study 20035207 — intervention group
Group type: EXPERIMENTAL
Intervention: HibMenCY‐TT
Number of subjects: 609
Study 20035207 — intervention group
Group type: COMPARATOR
Intervention: MPSV4
Number of subjects: 609
Study 20035207 — intervention group
Group type: COMPARATOR
Intervention: Hib‐TT
Number of subjects: 609
Study 18777125 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal fenestration (Group A, n = 50)
Number of subjects: 100
Study 18777125 — intervention group
Group type: COMPARATOR
Intervention: No peritoneal incisions (Group B, n = 50)
Number of subjects: 100
Study 18777125 — intervention group
Group type: EXPERIMENTAL
Intervention: Bilateral peritoneal fenestration (Group A)
Number of subjects: 100
Study 18777125 — intervention group
Group type: COMPARATOR
Intervention: No peritoneal incisions (Group B)
Number of subjects: 100
Study 17152731 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomimetic Vilon (Lys‐Glu) administration
Number of subjects: 0
Study 17152731 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment for DM‐1 patients
Number of subjects: 0
Study 17152731 — intervention group
Group type: EXPERIMENTAL
Intervention: Thymomimetic Vilon (Lys‐Glu) in elderly patients with severe DM‐1
Number of subjects: 0
Study 14974912 — intervention group
Group type: EXPERIMENTAL
Intervention: Leuprolide acetate (3.75 mg intramuscularly) plus tibolone (2.5 mg/day)
Number of subjects: 28
Study 14974912 — intervention group
Group type: COMPARATOR
Intervention: Leuprolide acetate (3.75 mg intramuscularly) plus placebo
Number of subjects: 28
Study 11881696 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual performance feedback intervention provided to nurses
Number of subjects: 240
Study 8706769 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 1 mg
Number of subjects: 24
Study 8706769 — intervention group
Group type: EXPERIMENTAL
Intervention: Levosimendan 2 mg
Number of subjects: 24
Study 8706769 — intervention group
Group type: COMPARATOR
Intervention: Captopril (50 mg b.i.d.) with levosimendan
Number of subjects: 24
Study 1404674 — intervention group
Group type: EXPERIMENTAL
Intervention: Color Doppler Imaging (CDI)
Number of subjects: 29
Study 3980061 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (125 mg)
Number of subjects: 15
Study 3980061 — intervention group
Group type: EXPERIMENTAL
Intervention: L-dopa (125 mg) plus carbidopa (12.5 mg)
Number of subjects: 15
Study 3980061 — intervention group
Group type: COMPARATOR
Intervention: Tyrosine load (100 mg/kg)
Number of subjects: 15
Study 3980061 — intervention group
Group type: COMPARATOR
Intervention: Meal low in phenylalanine and tyrosine
Number of subjects: 15
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: PDA media
Number of subjects: 0
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: YMA and MEA media
Number of subjects: 0
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: Barley and rye grains
Number of subjects: 0
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: Oat grains
Number of subjects: 0
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: 50% S + 50% C substrate
Number of subjects: 0
Study 31944082 — intervention group
Group type: EXPERIMENTAL
Intervention: Wheat straw (S) with SCG substrate
Number of subjects: 0
Study 31426299 — intervention group
Group type: EXPERIMENTAL
Intervention: L. plantarum HEAL9 and L. paracasei 8700:2 (probiotic group)
Number of subjects: 78
Study 31426299 — intervention group
Group type: COMPARATOR
Intervention: Maltodextrin (placebo group)
Number of subjects: 78
Study 28260548 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatbreads made with 15% chickpea flour (CPF) and 3% guar gum (GG)
Number of subjects: 56
Study 28260548 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatbreads made with 15% chickpea flour (CPF) and 4% guar gum (GG)
Number of subjects: 56
Study 28260548 — intervention group
Group type: COMPARATOR
Intervention: Control flatbreads made with 100% wheat flour
Number of subjects: 56
Study 26602073 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg plus Ezetimibe 10 mg
Number of subjects: 1873
Study 26602073 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1873
Study 23735724 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive structured monitoring (ISM) with 4-point glycemic profiles performed 3 days/week
Number of subjects: 1024
Study 23735724 — intervention group
Group type: COMPARATOR
Intervention: Active control (AC) with 4-point glycemic profiles performed at baseline and at 6 and 12 months
Number of subjects: 1024
Study 20639269 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised-response technique (RRT)
Number of subjects: 597
Study 20639269 — intervention group
Group type: COMPARATOR
Intervention: Direct questioning
Number of subjects: 597
Study 20639269 — intervention group
Group type: EXPERIMENTAL
Intervention: Randomised-response technique (RRT) with cheating detection
Number of subjects: 597
Study 20639269 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifetime prevalence estimation
Number of subjects: 597
Study 19797013 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonist (0.1 mg triptorelin administered on day 3 after embryo transfer)
Number of subjects: 180
Study 17026560 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline injection with detachable snare (group A)
Number of subjects: 159
Study 17026560 — intervention group
Group type: COMPARATOR
Intervention: Adrenaline injection alone (group B)
Number of subjects: 159
Study 12777340 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering off plus group CBT
Number of subjects: 180
Study 12777340 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapering off alone
Number of subjects: 180
Study 12777340 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 180
Study 11079673 — intervention group
Group type: EXPERIMENTAL
Intervention: Two-stage transesophageal atrial pacing stress echocardiography (TAPSE)
Number of subjects: 36
Study 9378207 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic duct injections (10 or more injections) in Group I
Number of subjects: 1979
Study 9378207 — intervention group
Group type: EXPERIMENTAL
Intervention: Difficult common bile duct cannulations in Group I
Number of subjects: 1979
Study 9378207 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall incidence of pancreatitis in Group I
Number of subjects: 1979
Study 8260242 — intervention group
Group type: EXPERIMENTAL
Intervention: 24-h psychological training program (P.T.P.)
Number of subjects: 72
Study 8260242 — intervention group
Group type: COMPARATOR
Intervention: Waiting list period (Control)
Number of subjects: 72
Study 3872304 — intervention group
Group type: EXPERIMENTAL
Intervention: Papaverine hydrochloride (1 mg in 10 cc normal saline)
Number of subjects: 17
Study 3872304 — intervention group
Group type: COMPARATOR
Intervention: Control (10 cc normal saline)
Number of subjects: 17
Study 30453984 — intervention group
Group type: EXPERIMENTAL
Intervention: Externally stented saphenous vein grafts
Number of subjects: 30
Study 30453984 — intervention group
Group type: COMPARATOR
Intervention: Nonstented saphenous vein grafts
Number of subjects: 30
Study 28947462 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesiotaping (KT) added to a rehabilitation programme
Number of subjects: 52
Study 28947462 — intervention group
Group type: COMPARATOR
Intervention: Rehabilitation programme without KT (no-KT)
Number of subjects: 52
Study 25082955 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercises in front of optokinetic stimuli during weeks 4-8
Number of subjects: 12
Study 25082955 — intervention group
Group type: COMPARATOR
Intervention: No intervention (control group)
Number of subjects: 12
Study 23219622 — intervention group
Group type: EXPERIMENTAL
Intervention: Posterior stabilized high flexion device
Number of subjects: 93
Study 23219622 — intervention group
Group type: COMPARATOR
Intervention: Posterior stabilized standard device
Number of subjects: 93
Study 22041948 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive CD-ROM about responding to patients' negative emotions
Number of subjects: 312
Study 22041948 — intervention group
Group type: COMPARATOR
Intervention: Control group (communication lecture)
Number of subjects: 312
Study 18436153 — intervention group
Group type: EXPERIMENTAL
Intervention: Cilostazol
Number of subjects: 1435
Study 18436153 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1435
Study 16956818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid iv every 6 months (group A)
Number of subjects: 66
Study 16956818 — intervention group
Group type: EXPERIMENTAL
Intervention: 4 mg zoledronic acid iv every 3 months (group B)
Number of subjects: 66
Study 16956818 — intervention group
Group type: COMPARATOR
Intervention: Placebo every 3 months (group C)
Number of subjects: 66
Study 15314993 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamazole
Number of subjects: 100
Study 15314993 — intervention group
Group type: EXPERIMENTAL
Intervention: 131I
Number of subjects: 100
Study 15314993 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 100
Study 10551639 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST) administered 24 hr before transplant and 7-10 days posttransplant
Number of subjects: 212
Study 10551639 — intervention group
Group type: COMPARATOR
Intervention: Control group (no DST)
Number of subjects: 212
Study 10551639 — intervention group
Group type: EXPERIMENTAL
Intervention: Donor-specific transfusion (DST)
Number of subjects: 212
Study 10551639 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood stored for > or =3 days
Number of subjects: 212
Study 10551639 — intervention group
Group type: EXPERIMENTAL
Intervention: Transfused patients with more class I antigen mismatches
Number of subjects: 212
Study 10551639 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall class II antigen mismatches
Number of subjects: 212
Study 8722732 — intervention group
Group type: EXPERIMENTAL
Intervention: Heel lift (6 patients)
Number of subjects: 12
Study 8722732 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic insoles (6 patients)
Number of subjects: 12
Study 1716338 — intervention group
Group type: EXPERIMENTAL
Intervention: MACOP-B
Number of subjects: 267
Study 1716338 — intervention group
Group type: COMPARATOR
Intervention: F-MACHOP
Number of subjects: 267
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc intake at greater than 150 micrograms/kg/day
Number of subjects: 38
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intake at greater than 16 micrograms/kg/day
Number of subjects: 38
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc intake at 438 micrograms/kg/day
Number of subjects: 38
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intake at 63 micrograms/kg/day
Number of subjects: 38
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc intake ranging from 91 to 824 micrograms/kg/day
Number of subjects: 38
Study 6411885 — intervention group
Group type: EXPERIMENTAL
Intervention: Copper intake ranging from 8 to 92 micrograms/kg/day
Number of subjects: 38
Study 30550151 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with distant metastasis (n=37)
Number of subjects: 74
Study 30550151 — intervention group
Group type: COMPARATOR
Intervention: Patients without distant metastasis (n=37)
Number of subjects: 74
Study 30550151 — intervention group
Group type: EXPERIMENTAL
Intervention: Distant metastasis characteristics
Number of subjects: 74
Study 30550151 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors analyzed
Number of subjects: 74
Study 30550151 — intervention group
Group type: EXPERIMENTAL
Intervention: AJCC staging and pigment deposition
Number of subjects: 74
Study 25582800 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness-based cognitive therapy for children (MBCT-C)
Number of subjects: 10
Study 24670086 — intervention group
Group type: EXPERIMENTAL
Intervention: Pancreatic enzyme replacement therapy (PERT) (50,000 IU lipase)
Number of subjects: 14
Study 24670086 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study 22527559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal prolapse repair with mesh
Number of subjects: 65
Study 22527559 — intervention group
Group type: COMPARATOR
Intervention: Vaginal prolapse repair without mesh
Number of subjects: 65
Study 22527559 — intervention group
Group type: EXPERIMENTAL
Intervention: Vaginal prolapse repair (with or without mesh)
Number of subjects: 65
Study 22527559 — intervention group
Group type: EXPERIMENTAL
Intervention: Achieving first goal
Number of subjects: 65
Study 20064730 — intervention group
Group type: EXPERIMENTAL
Intervention: Endovenous laser ablation (EVLA)
Number of subjects: 121
Study 20064730 — intervention group
Group type: COMPARATOR
Intervention: Saphenofemoral ligation and stripping of the great saphenous vein (surgery)
Number of subjects: 121
Study 17315079 — intervention group
Group type: EXPERIMENTAL
Intervention: Management options for weight loss in Alzheimer's disease
Number of subjects: 0
Study 17315079 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural history of weight loss in Alzheimer's disease
Number of subjects: 0
Study 17315079 — intervention group
Group type: EXPERIMENTAL
Intervention: Etiological factors of weight loss in Alzheimer's disease
Number of subjects: 0
Study 17315079 — intervention group
Group type: EXPERIMENTAL
Intervention: Consequences of weight loss in Alzheimer's disease
Number of subjects: 0
Study 15764622 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternating pressure air mattress (APAM) - Alpha‐X‐Cell, Huntleigh Healthcare, UK
Number of subjects: 447
Study 15764622 — intervention group
Group type: COMPARATOR
Intervention: Visco-elastic foam mattress (Tempur, Tempur-World Inc., USA) with turning every 4 hours
Number of subjects: 447
Study 11882513 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose glucose infusion at a mean rate of 6 mg x kg(‐1) x min(‐1)
Number of subjects: 7
Study 11882513 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose glucose infusion at a mean rate of 12 mg x kg(‐1) x min(‐1)
Number of subjects: 7
Study 9878012 — intervention group
Group type: EXPERIMENTAL
Intervention: 125 mg famciclovir
Number of subjects: 248
Study 9878012 — intervention group
Group type: EXPERIMENTAL
Intervention: 250 mg famciclovir
Number of subjects: 248
Study 9878012 — intervention group
Group type: EXPERIMENTAL
Intervention: 500 mg famciclovir
Number of subjects: 248
Study 9878012 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 248
Study 7626850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cisplatin 100 mg/m2 and Cyclophosphamide 1200 mg/m2
Number of subjects: 105
Study 7626850 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin 80 mg/m2 and Cyclophosphamide 900 mg/m2
Number of subjects: 105
Study 1903370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture only
Number of subjects: 85
Study 1903370 — intervention group
Group type: EXPERIMENTAL
Intervention: Lecture and clinical practice
Number of subjects: 85
Study 1903370 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail)
Number of subjects: 85
Study 6795656 — intervention group
Group type: EXPERIMENTAL
Intervention: Maprotiline (up to 150 mg/day for 2 weeks, then up to 300 mg/day if indicated)
Number of subjects: 28
Study 31801485 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopy
Number of subjects: 276
Study 31801485 — intervention group
Group type: COMPARATOR
Intervention: Laparotomy
Number of subjects: 276
Study 29089313 — intervention group
Group type: EXPERIMENTAL
Intervention: RADPAD
Number of subjects: 766
Study 29089313 — intervention group
Group type: COMPARATOR
Intervention: SHAMPAD
Number of subjects: 766
Study 25705005 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel drug-eluting balloon (DEB)
Number of subjects: 182
Study 25705005 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stent (PES)
Number of subjects: 182
Study 22803597 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 20 mg twice daily
Number of subjects: 131
Study 22803597 — intervention group
Group type: EXPERIMENTAL
Intervention: Atomoxetine 60 mg twice daily
Number of subjects: 131
Study 22803597 — intervention group
Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg
Number of subjects: 131
Study 22803597 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 131
Study 21363899 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 880
Study 21363899 — intervention group
Group type: COMPARATOR
Intervention: Conventional ward treatment
Number of subjects: 880
Study 19140995 — intervention group
Group type: EXPERIMENTAL
Intervention: Testing as the final activity in the skills course (3.5 hours of instruction and training followed by 30 minutes of testing)
Number of subjects: 140
Study 19140995 — intervention group
Group type: COMPARATOR
Intervention: Control course (4 hours of instruction and training)
Number of subjects: 140
Study 17543656 — intervention group
Group type: EXPERIMENTAL
Intervention: RSI plus etomidate bolus followed by continuous sedative infusion (ETO group)
Number of subjects: 41
Study 17543656 — intervention group
Group type: COMPARATOR
Intervention: RSI plus placebo followed by continuous sedative infusion (placebo group)
Number of subjects: 41
Study 12737240 — intervention group
Group type: EXPERIMENTAL
Intervention: Mandibular overdenture supported by two endosseous implants with a connecting bar
Number of subjects: 102
Study 12737240 — intervention group
Group type: COMPARATOR
Intervention: Conventional denture
Number of subjects: 102
Study 10927737 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa-bran cereal (25.0 g/d of total dietary fiber)
Number of subjects: 25
Study 10927737 — intervention group
Group type: COMPARATOR
Intervention: Low-fiber cereal (5.6 g/d of total dietary fiber)
Number of subjects: 25
Study 8723472 — intervention group
Group type: EXPERIMENTAL
Intervention: Trimethoprim (200 mg)
Number of subjects: 8